Английская Википедия:Andrew Le

Материал из Онлайн справочника
Версия от 13:16, 31 января 2024; EducationBot (обсуждение | вклад) (Новая страница: «{{Английская Википедия/Панель перехода}} {{Short description|American medical researcher}} {{Orphan|date=August 2023}} '''Andrew Le''' is an American medical researcher.<ref name=":0">{{cite web |last1=Morrison |first1=Jim |title=Andrew Le's startup offers help to patients drowning in medical information |url=https://www.bizjournals.com/boston/news/2020/12/02/andrew-les-startup-offers-help-to-patients-drowni.html |website=ww...»)
(разн.) ← Предыдущая версия | Текущая версия (разн.) | Следующая версия → (разн.)
Перейти к навигацииПерейти к поиску

Шаблон:Short description Шаблон:Orphan

Andrew Le is an American medical researcher.[1] He research and publishes his work on AI use in healthcare and brain cancer.[2]

Life and education

He was born in the United States to Vietnamese immigrants who escaped Vietnam by boat in 1979.[3] He attended Taylor High School, where he actively participated in charity work, raising funds for shelters after Hurricane Katrina.[4]

He pursued higher education at Harvard College, graduating magna cum laude and Phi Beta Kappa.[5] He then earned his doctorate of medicine from Harvard Medical School, specializing in neurosurgery.[6]

Career and research

During his medical training, he observed patients frequently resorting to online symptom searches, leading to misinformation and potential harm to their health.[7] While a third-year medical resident at Harvard Medical School in 2014, Le co-founded Buoy Health with his colleague Eddie Reyes.[8] He developed an AI-powered digital health tool that would function as a health-specific search engine, offering patients information and guidance.[1]

Le and his colleagues gathered enough data to educate the algorithm by hand-reading the 18,000-plus articles, then developing an algorithm to crunch the figures in real-time for everyone.[8]

He looked at 100 standardized cases with 33 varied diagnoses, ranging from a harmless cough to a potentially fatal pulmonary embolism, as well as the incidence of uncommon illnesses like histoplasmosis and the common cold.[7]

He has led Buoy through two successful investment rounds, raising over $67 million with healthcare investors like Optum, Cigna, Humana, and WR Hambrecht + Co, since establishing the firm out of Harvard Innovation Labs in 2014.[9]

Selected publications

References

Шаблон:Reflist

Шаблон:Authority control